Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “End-of-Life”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07545512
What this trial is testing

ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY

Who this might be right for
Myocardial Infarction (MI)Sudden Cardiac Death Due to Cardiac Arrhythmia
University Hospital, Clermont-Ferrand 400
Not applicableStudy completedNCT04607265
What this trial is testing

Sudden Death Stratification

Who this might be right for
Non-ischemic Cardiomyopathy
Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)WithdrawnNCT03780634
What this trial is testing

HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Not applicableStudy completedNCT03654157
What this trial is testing

ACS Registry - A Non-interventional Study to Estimate the Rates of Outcomes in ACS Patients in Moscow

Who this might be right for
Heart AttackStrokeCardiovascular Death
AstraZeneca 1,576
Not applicableStudy completedNCT04598165
What this trial is testing

Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support

Who this might be right for
Neonatal DeathPerinatal DeathDepression
Women and Infants Hospital of Rhode Island 5,020
Large-scale testing (Phase 3)Study completedNCT03920540
What this trial is testing

GC1111 in Hunter Syndrom Patients

Who this might be right for
Hunter Syndrome
Green Cross Corporation 32
Not applicableStudy completedNCT03364179
What this trial is testing

IssuEs in Palliative Care for People in Advanced and Terminal Stages of Young-onset and Late-Onset Dementia in GErmany

Who this might be right for
Advanced Dementia StagesPalliative Care
Technical University of Munich 300
Not applicableStudy completedNCT01990742
What this trial is testing

Improving Palliative Care Through Teamwork

Who this might be right for
Palliative Care
University of Rochester 31
Large-scale testing (Phase 3)UnknownNCT05661240
What this trial is testing

Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd 348
Not applicableStudy completedNCT03332979
What this trial is testing

Experiencing Loss and Planning Ahead Study

Who this might be right for
Grief
University College, London 150
Not applicableUnknownNCT03485079
What this trial is testing

A Prospective,Multiple Center,Cohort Study of Prediction Model on Sudden Cardiac Death and Devices Development by Automatic Analysis From 24h Electrocardiogram in China

Who this might be right for
Sudden Cardiac Death
Jingfeng Wang 2,200
Not applicableStudy completedNCT03290924
What this trial is testing

Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach

Who this might be right for
StillbirthNeonatal Death
Jhpiego 40
Testing effectiveness (Phase 2)Looking for participantsNCT06413680
What this trial is testing

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Who this might be right for
MelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors
Regeneron Pharmaceuticals 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT05907096
What this trial is testing

ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function

Who this might be right for
Delayed Graft Function
argenx 103
Not applicableStudy completedNCT03007017
What this trial is testing

Novel Strategies for Innovating Deceased Donor Procurement

Who this might be right for
Kidney Failure, Chronic
University of Maryland, Baltimore 2
Not applicableStudy completedNCT04358029
What this trial is testing

Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19)

Who this might be right for
COVID 19 CardiacCOVID 16 ArrhythmiaCOVID 19 Death
Vivek Reddy 4,000
Testing effectiveness (Phase 2)Looking for participantsNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28
Large-scale testing (Phase 3)Active Not RecruitingNCT05732805
What this trial is testing

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

Who this might be right for
MelanomaMelanoma (Skin)Melanoma Stage III+4 more
Biocad 270
Testing effectiveness (Phase 2)Active Not RecruitingNCT06307431
What this trial is testing

Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 272
Not applicableStudy completedNCT02091622
What this trial is testing

Increasing the Number of Patients Receiving Information About Transition to End-of-life Care

Who this might be right for
Palliative CareDisclosure
Umeå University 1,431
Next Page